Published in PLoS Negl Trop Dis on September 21, 2016
Rabies re-examined. Lancet Infect Dis (2002) 3.76
Overview of rabies in the Americas. Virus Res (2005) 3.11
Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods (1998) 2.33
Novel lyssavirus in Natterer's bat, Germany. Emerg Infect Dis (2011) 1.71
Rabies transmitted by vampire bats to humans: an emerging zoonotic disease in Latin America? Rev Panam Salud Publica (2009) 1.60
Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet. Emerg Infect Dis (2012) 1.59
Sexual dimorphism of humoral immunity with human vaccines. Vaccine (2008) 1.56
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ (2000) 1.50
Ecological and anthropogenic drivers of rabies exposure in vampire bats: implications for transmission and control. Proc Biol Sci (2012) 1.42
Human rabies due to lyssavirus infection of bat origin. Vet Microbiol (2010) 1.37
Bat-transmitted human rabies outbreaks, Brazilian Amazon. Emerg Infect Dis (2006) 1.33
Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet (1997) 1.10
Present and potential future distribution of common vampire bats in the Americas and the associated risk to cattle. PLoS One (2012) 1.07
Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis (2010) 1.03
Complete genome sequence of Ikoma lyssavirus. J Virol (2012) 1.00
Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg (1999) 0.97
Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Hum Vaccin Immunother (2012) 0.95
Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J (1998) 0.94
Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis (1998) 0.89
Vaccinating the vampire bat Desmodus rotundus against rabies. Virus Res (2008) 0.88
An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies. J Med Microbiol (2009) 0.88
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J (2009) 0.88
Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg (2008) 0.82
Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam. J Trop Pediatr (2007) 0.81
Rabies: Knowledge and Practices Regarding Rabies in Rural Communities of the Brazilian Amazon Basin. PLoS Negl Trop Dis (2016) 0.79
Booster vaccination at 1 year with a rabies vaccine associated with DTP-IPV in infants living in a rabies endemic country. J Trop Pediatr (1999) 0.77
The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med (2003) 0.77